Veeva OpenData Review 2026

B2B Contact & Company Data

Last updated: 2026-06-03

Visit Veeva OpenData → See All B2B Data Tools

The Bottom Line

Veeva OpenData is for life-sciences companies that have already committed to Veeva CRM and want provider data that plugs straight in. The native integration is the whole pitch: no middleware, no data-matching project, clean HCP and HCO records inside the tools reps already use, with compliance and stewardship baked in. For a Veeva shop, it's the obvious default, and the expanding 110-country footprint makes it viable for multinationals standardizing on one provider.

The trade-off is lock-in and pricing opacity. OpenData's value is tightly coupled to the Veeva ecosystem, so if you don't run Veeva CRM, you're effectively buying a platform to get a data feed. Pricing bundled into the broader Veeva relationship makes standalone data cost hard to judge, and international depth in some markets still trails IQVIA despite the broad country count. This is a data product that assumes a CRM decision has already been made.

Buy OpenData if you run Veeva CRM and want the simplest, best-integrated path to HCP and HCO data with strong compliance features. Choose IQVIA OneKey instead if global coverage depth in hard markets matters more than native integration and you aren't tied to Veeva. If you don't run Veeva at all, look at a provider that fits your existing CRM rather than buying into a whole ecosystem for the data alone. OpenData wins clearly inside Veeva, and makes much less sense outside it.

What is Veeva OpenData?

Veeva OpenData is a b2b contact & company data tool. Provider reference data built into the Veeva CRM ecosystem. If you already run Veeva, OpenData is the path of least resistance. Otherwise, you're buying into a whole ecosystem.

Best for: Life sciences companies already using Veeva CRM who need integrated provider data

Best For

Life sciences companies already using Veeva CRM who need integrated provider data

Veeva OpenData Overview

Veeva OpenData is the provider reference data that lives inside the Veeva ecosystem. If your life-sciences company already runs Veeva CRM or Vault, OpenData is the path of least resistance for HCP and HCO data, because it's built to plug straight in with no middleware and no messy data-matching project. It supplies the physician and organization records that field teams call on, complete with affiliations, addresses, and the compliance metadata regulated industries need.

Coverage has expanded a lot. OpenData now spans 110-plus countries, including roughly 12 million HCPs and 2 million HCOs in the US alone, plus millions more across Europe, Latin America, Asia Pacific, and the Middle East and Africa. That global footprint, paired with native Veeva integration, is why so many pharma and biotech commercial teams default to it once they're committed to the Veeva stack.

The 2025 OpenData Live release widened access beyond field reps. It's a web application that lets market access, compliance, and key-account-management teams pull real-time HCP and HCO data directly, rather than waiting on data stewardship requests. For organizations where multiple functions need the same trusted provider records, that broader access reduces the friction of everyone working off a single source.

The honest limitation is lock-in. OpenData's value is tightest when you're already a Veeva CRM customer, and its pricing is bundled into that ecosystem, which makes standalone value hard to assess. If you don't run Veeva, you're effectively buying into a whole platform to get the data, and international coverage, while broad, still trails IQVIA in depth in some markets. This is a data product that assumes you've already picked your CRM team.

Pros & Cons

Native Veeva integration with no middlewareOpenData is built to feed Veeva CRM and Vault directly, so there's no separate integration project, no data-matching layer, and no stale-sync headaches. For a Veeva shop, that means HCP and HCO records show up clean and current inside the tools reps already use. The integration is the single biggest reason existing Veeva customers choose OpenData over a third-party feed.
Strong compliance and stewardship featuresLife sciences operates under aggregate-spend reporting, opt-out tracking, and strict data-governance rules, and OpenData is built with that in mind. Data stewardship workflows, change requests, and audit trails are part of the product rather than bolted on. For regulated commercial teams, having compliance baked into the reference data reduces the risk of reporting gaps that come back to bite at audit time.
Broad global coverageOpenData spans 110-plus countries, with around 12 million HCPs and 2 million HCOs in the US and millions more across Europe, LatAm, APAC, and the Middle East and Africa. For a multinational pharma running field teams across regions, having one provider for most markets simplifies governance and territory alignment. The footprint has grown substantially over the past few years, narrowing the gap with the largest reference-data vendors.
OpenData Live extends access across the orgThe 2025 OpenData Live web app gives market access, compliance, and KAM teams real-time HCP and HCO lookups without routing every request through data stewards. That means functions outside the field force work off the same trusted records instead of maintaining shadow spreadsheets. For organizations standardizing on one source of provider truth, the broader access closes a real operational gap.

Locked into the Veeva ecosystemOpenData's strongest selling point is native Veeva integration, which is also its biggest constraint. If you don't run Veeva CRM, much of the value evaporates and you're buying into a platform decision to get a data feed. For non-Veeva shops, a standalone provider that integrates with your existing CRM is usually the better fit and a smaller commitment.
Weaker international depth than IQVIA in some marketsOpenData's country count is broad, but record depth and accuracy in certain international markets still trail IQVIA, which has decades of pharmaceutical data infrastructure abroad. For teams whose growth depends on hard-to-cover emerging markets, that gap can matter. Validate coverage in your specific priority countries rather than assuming the 110-country headline applies evenly everywhere.
Bundled pricing obscures standalone valueOpenData is typically priced within the broader Veeva relationship, and the per-record model with country caps isn't always transparent in a bundle. That makes it hard to know what you're really paying for data versus CRM versus other Veeva modules. Buyers should push for line-item clarity so they can compare the data cost against alternatives on an apples-to-apples basis.
Per-record costs add up in large marketsOpenData is priced by HCP and HCO records per country, with a cap per country. Licensing all physicians in a large market like the US can still run into six figures per year if it isn't negotiated carefully. Teams should scope which specialties and geographies they actually need rather than licensing the full national file by default and overpaying for records they'll never call on.

Use Cases

Global Pharma Standardizing Provider Data Across Regions

A multinational pharma company runs Veeva CRM across the US, Europe, and Asia but has been stitching together different reference-data vendors by region, creating mismatched records and governance headaches. They consolidate onto Veeva OpenData to get HCP and HCO data for most of their priority markets from one provider, natively integrated with the CRM their reps already use. Data stewardship and compliance workflows become consistent across regions, and territory alignment stops breaking on inconsistent provider records. The commercial-ops team cuts the time spent reconciling data across regions substantially and reduces compliance risk from inconsistent aggregate-spend reporting.

Biotech Launching with a Veeva-Native Field Team

A growing biotech is standing up its first commercial field team and has chosen Veeva CRM as the system of record. Rather than running a separate data integration project, they adopt OpenData so reps get clean, current HCP records inside the CRM from day one. The native connection means no middleware to build or maintain, which matters for a lean team without a large IT function. The field team launches on schedule with trusted provider data, and compliance has the stewardship trail it needs for spend reporting from the start of the launch.

Market Access Team Using OpenData Live for Real-Time Lookups

A pharma market-access team needs accurate HCP and HCO information to support payer and account strategy, but historically had to request records through data stewards, adding days of delay. With OpenData Live, the team pulls real-time provider and organization data directly through the web app without waiting on the field-CRM workflow. They validate account hierarchies and provider affiliations on demand while building access strategy. Decisions that used to stall on data requests now happen in the same meeting, and the whole organization works off the same trusted source instead of separate spreadsheets.

Key Features

HCP reference data
Veeva CRM integration
Compliance tracking
Affiliation data
Territory alignment
Data stewardship

Pricing

Plan	Price
Bundled with Veeva CRM	Custom

Pricing as of 2026. Check Veeva OpenData's website for current pricing.

Pricing Analysis

Veeva OpenData uses a subscription model priced by data scope rather than per user. Cost is driven by the number of HCP and HCO records you license and the countries you cover, with a defined maximum fee cap per country. So a small specialty file in one market is inexpensive, while licensing all physicians across several large markets climbs quickly.

In practice, OpenData is usually quoted within a broader Veeva relationship, and pricing is custom and not published. That bundling makes standalone data cost hard to isolate, which is why buyers should insist on line-item visibility into the data spend separate from CRM and other Veeva modules. Licensing a full national HCP file in a large market like the US can run into six figures annually if it isn't scoped and negotiated with care.

The right approach is to scope tightly: identify the specialties, geographies, and record types your field and access teams actually need, then license to that footprint rather than buying the entire national file by default. Because the value is so tied to native Veeva integration, the pricing comparison that matters is OpenData inside your existing Veeva stack versus the cost and integration burden of a third-party feed bolted onto a different CRM.

Frequently Asked Questions

Do I need Veeva CRM to use OpenData?

Practically, yes. OpenData's main advantage is native integration with Veeva CRM and Vault, and most of its value comes from that connection. You can technically license the data, but without the Veeva stack you lose the no-middleware integration that makes it compelling. Non-Veeva shops are usually better served by a provider that integrates with their existing CRM.

How much does Veeva OpenData cost?

Pricing is custom and based on data scope, not per user. It's priced by HCP and HCO records per country with a per-country cap, and it's usually bundled into a broader Veeva agreement. Licensing a full national physician file in a large market can reach six figures per year. Scope tightly to the specialties and geographies you actually need to control cost.

How many countries and providers does OpenData cover?

OpenData spans 110-plus countries, including roughly 12 million HCPs and 2 million HCOs in the US, plus millions more across Europe, Latin America, Asia Pacific, and the Middle East and Africa. The footprint has expanded significantly in recent years. Depth varies by market, so validate coverage in your specific priority countries rather than relying on the global headline number.

How does OpenData compare to IQVIA OneKey?

IQVIA still has deeper international coverage and longer-standing data infrastructure in many markets. OpenData's edge is native Veeva integration, modern stewardship workflows, and a strong US dataset. If you run Veeva CRM, OpenData is the simpler choice. If global depth in hard-to-cover markets is your priority and you're not tied to Veeva, IQVIA may serve you better.

What is OpenData Live?

OpenData Live is a 2025 web application that extends real-time HCP and HCO data access beyond the field force to market access, compliance, and key-account-management teams. Instead of routing every data request through stewards, those functions can look up trusted provider records directly. It's aimed at organizations that want the whole commercial org working from one source of provider truth.

Similar Tools

By Rome Thorndike

Reviewed by Rome Thorndike. Last verified 2026-06-03.

Pricing, features, and ratings are based on vendor documentation, public filings, product demos, and feedback from sales teams using these tools in production. We update reviews when vendors ship major releases or change pricing.